Suchergebnisse

Central Garden & Pet Company CENT has announced a strategic partnership with Phillips Pet Food & Supplies to establish a new pet distribution joint venture aimed at strengthening nationwide

Phillips 66 (PSX) ended the recent trading session at $158.76, demonstrating a -1.02% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of

Philip Morris (PM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook

Philip Morris International Inc. PM is likely to register growth in both top and bottom lines when it reports first-quarter 2026 earnings on April 22. The Zacks Consensus Estimate for revenues is

In its upcoming report, Philip Morris (PM) is predicted by Wall Street analysts to post quarterly earnings of $1.82 per share, reflecting an increase of 7.7% compared to the same period last year

Philip Morris International Inc. PMI has received renewed regulatory backing in the United States, as the Food and Drug Administration (“FDA”) reauthorized its IQOS heated tobacco system as a

Phillips 66 (PSX) ended the recent trading session at $159.38, demonstrating a +2.33% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of

Philip Morris (PM) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.69 per share a year ago. These

For the quarter ended March 2026, Philip Morris (PM) reported revenue of $10.15 billion, up 9.1% over the same period last year. EPS came in at $1.96, compared to $1.69 in the year-ago quarter.

The

Phillips 66 (PSX) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a

Philip Morris International Inc. PM reported first-quarter 2026 results, wherein both top and bottom lines beat the Zacks Consensus Estimate and increased year over year. The company delivered a

Phillips Edison & Company, Inc. (PECO) came out with quarterly funds from operations (FFO) of $0.69 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to FFO of $0.65

Phillips Edison & Company, Inc. (PECO) reported $190.74 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 7%. EPS of $0.69 for the same period compares

Phillips 66 PSX is set to report first-quarter 2026 results on April 29, before the opening bell.

Let us examine the factors that are expected to have impacted this refiner’s quarterly performance

Wall Street analysts forecast that Phillips 66 (PSX) will report quarterly loss of -$0.55 per share in its upcoming release, pointing to a year-over-year increase of 38.9%. It is anticipated that

For Immediate Release

Chicago, IL – April 28, 2026 – Today, Zacks Equity Research discusses Phibro Animal Health PAHC, BioLife Solutions BLFS, Omeros OMER and Brainsway BWAY.

Industry: Medical

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Insulet (PODD). But which of these two stocks offers value investors a better bang for

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different